Sign in to view content

Inhibition of Complement C3 in GA with NGM621: Phase 1 Study Results

David A. Eichenbaum, MD, FASRS

Video
Published 2021

Related

Avacincaptad Pegol, A Novel C5 Inhibitor, Reached Statistical Significance in a Pivotal Clinical Trial for Geographic Atrophy Secondary to Dry AMD
Baruch D. Kuppermann, MD, PhD
Annual Meeting Talks
2020
Intravitreal Injections and Cataract Surgery Wrong Eye Billing Errors Found in EMR
Deepika Malik, MD
On Demand Cases, Courses, and Papers
2019
Clinical and Demographic Factors Associated With Loss to Follow-up in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Durga Borkar, MD
Annual Meeting Talks
2021

Category: Pharmacology

See more